← SynDRA
BELNACASAN
SynDRA canonical compound SYN0033264 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASP1 |
|---|
| Mechanism of action | caspase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CASP1 INHIBITOR
- Caspase-1 inhibitor
- CASP4 INHIBITOR
- caspase inhibitor
Cross-references
Synonyms
- Belcanasan
- Vx-765
- VX765
- Second generation ICE inhibitors, Vertex
- VRT-043198
- VRT-43198
- VX-765
- VX-765)
- VX 765
- belcanasan
- belnacasanum
- RefChem:116925
- VX-765 hemiketal
- Belnacasan (VX-765)
- Belnacasan (VX765)
- Belnacasan(VX-765)
- vx-765 (Belnacasan)
- MFCD11100350
- Belnacasan [USAN]
- UNII-00OLE78529
- Belnacasan [USAN:INN]
- C24H33ClN4O6
- BELNACASAN [INN]
- Belnacasan (USAN/INN)
- Belnacasan (VX-765)?
- BELNACASAN [WHO-DD]
- GTPL9035
- orb1301082
- SCHEMBL3393597
- SCHEMBL29379933
- CHEBI:188567
- GLXC-90105
- HMS3884B11
- s2228
- AKOS024464751
- CCG-269769
- NCGC00183682-09
- NCGC00183682-10
Look up BELNACASAN in the interactive SynDRA portal →